Jiang-bo Sun
Fuzhou, 350005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
OTUB2/ALYREF axis modulates the docetaxel resistance of castration-resistant prostate cancer via upregulating ABCG4-mediated drug efflux.
Journal: International journal of biological sciences
Published: October 05, 2025
Comprehensive Analysis Identifies Tumor Mutation Burden-associated Genes ASPM and KIF11 as Novel Biomarkers for Adrenocortical Carcinoma.
Journal: Current cancer drug targets
Published: March 04, 2025
A Neuroendocrine Differentiation-related Molecular Model for Prognosis Prediction in Prostate Cancer Patients.
Journal: Current medicinal chemistry
Published: October 07, 2024
Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer.
Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer.
Journal: Frontiers in oncology
Published: February 07, 2023
A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients.
Journal: International journal of molecular sciences
Published: December 04, 2022
Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration-resistant prostate cancer.
Journal: Cancer medicine
Published: September 05, 2022
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 18, 2022
Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.
Journal: Journal of cancer research and clinical oncology
Published: August 06, 2022
A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients.
Journal: Computers in biology and medicine
Published: February 28, 2022
A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Journal: Frontiers in cell and developmental biology
Published: September 12, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026